China Resources Pharmaceutical Group Limited (HKG: 3320)
Hong Kong
· Delayed Price · Currency is HKD
5.43
-0.03 (-0.55%)
Dec 20, 2024, 4:08 PM HKT
China Resources Pharmaceutical Group Revenue
China Resources Pharmaceutical Group had revenue of 64.30B CNY in the quarter ending June 30, 2024, with 4.71% growth. This brings the company's revenue in the last twelve months to 250.48B, up 11.50% year-over-year. In the year 2023, China Resources Pharmaceutical Group had annual revenue of 244.70B with 12.16% growth.
Revenue (ttm)
250.48B CNY
Revenue Growth
+11.50%
P/S Ratio
0.13
Revenue / Employee
3.43M CNY
Employees
72,986
Market Cap
34.11B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 244.70B | 26.52B | 12.16% |
Dec 31, 2022 | 218.18B | -18.62B | -7.86% |
Dec 31, 2021 | 236.81B | 36.38B | 18.15% |
Dec 31, 2020 | 200.42B | -4.03B | -1.97% |
Dec 31, 2019 | 204.45B | 14.76B | 7.78% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionChina Resources Pharmaceutical Group News
- 2 months ago - Health product chain store CR Care to close all 19 branches in Hong Kong in November - Hong Kong Free Press